Drug: VER-01: chronic pain clinical trials
Registry records that list "Drug: VER-01" as an intervention. Being studied does not mean an intervention works or is approved.
0
Trials with Canadian sites
0
Recruiting in Canada
4
Registry records in total
Trials in Canada
No trial with a Canadian site lists this intervention in this snapshot.
Trials worldwide (outside Canada)
4 trials, 1 recruiting or not yet recruiting. Recruiting first.
| Phase | Countries | ||||
|---|---|---|---|---|---|
| Efficacy and Safety of VER-01 in the Treatment of Participants With Chronic Painful Lumbosacral Radiculopathy NCT06956014 | Recruiting | Phase 3 | United States | Vertanical GmbH | 2026-09-22 |
| Dose-Response Characterization of VER-01 in the Treatment of Patients With Chronic Non-specific Low Back Pain NCT06475001 | Completed | Phase 2 | United Kingdom | Vertanical GmbH | 2024-06-28 |
| Comparison of VER-01 to Opioids in Patients With Chronic Non-specific Low Back Pain NCT05610813 | Completed | Phase 3 | Germany | Vertanical GmbH | 2023-06-08 |
| Efficacy and Safety of VER-01 in the Treatment of Patients With Chronic Non-specific Low Back Pain NCT04940741 | Completed | Phase 3 | Germany | Vertanical GmbH | 2021-07-07 |
Conditions studied with this intervention
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status.